The probiotic Bifidobacterium in the management of Coronavirus: A theoretical basis
dc.authorid | Bozkurt, Hüseyin S/0000-0003-2097-2950 | en_US |
dc.contributor.author | Bozkurt, Hüseyin S. | |
dc.contributor.author | Quigley, Eamonn M. M. | |
dc.date.accessioned | 2024-07-12T21:40:49Z | |
dc.date.available | 2024-07-12T21:40:49Z | |
dc.date.issued | 2020 | en_US |
dc.department | [Belirlenecek] | en_US |
dc.description.abstract | COVID-19 is a viral pandemic that primarily manifests with respiratory distress but may also lead to symptoms and signs associated with the gastrointestinal tract. It is characteristically associated with a hyper-immune response, also referred to as a 'cytokine storm'. Probiotics are living microorganisms that have been shown to have positive effects on immune response in man with some bacteria; some strains of Bifidobacteria, for example, possess especially potent immune modulating effects. These bacteria have the potential to ameliorate the 'cytokine storm' through a differential effect on pro- and anti-inflammatory cytokines. In the management of COVID-19 and other coronovirus-mediated illnesses, probiotic bacteria also have the potential to enhance vaccine efficacy. | en_US |
dc.identifier.doi | 10.1177/2058738420961304 | |
dc.identifier.issn | 0394-6320 | |
dc.identifier.issn | 2058-7384 | |
dc.identifier.pmid | 33103512 | en_US |
dc.identifier.scopus | 2-s2.0-85094633206 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.uri | https://doi.org/10.1177/2058738420961304 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12415/7481 | |
dc.identifier.volume | 34 | en_US |
dc.identifier.wos | WOS:000588306200001 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | en_US |
dc.publisher | Sage Publications Inc | en_US |
dc.relation.ispartof | International Journal of Immunopathology And Pharmacology | en_US |
dc.relation.publicationcategory | Diğer | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.snmz | KY08838 | |
dc.subject | Bifidobacterium | en_US |
dc.subject | Covid-19 | en_US |
dc.subject | Probiotic | en_US |
dc.title | The probiotic Bifidobacterium in the management of Coronavirus: A theoretical basis | en_US |
dc.type | Editorial | |
dspace.entity.type | Publication |